Logo of Intelicare (ASX:ICR)Latest Intelicare (ASX:ICR) News

Page 1
Page 1 of 3

Technology Wrap - Week 44 (26 Oct -> 30 Oct) 2026

Technology shares swung widely this week, with DXN and Spectur hit by heavy selling while ION Video surged on new testing programmes. Cash shortages remained a major concern, even as software companies reported stronger recurring sales and new enterprise deals.
Logan Eniac
31 Oct 2026

InteliCare faces 1.1-quarter cash runway as aged care rollouts ramp up

InteliCare ended the September quarter with A$1.394 million in cash after an operating cash outflow of A$1.271 million, leaving just 1.10 quarters of estimated funding. The company is relying on customer receipts from expanding deployments, while continuing to assess funding options.
Sophie Babbage
30 Oct 2026

InteliCare turns aged care pilots into an $8.8 million rollout platform

InteliCare Holdings Limited (ASX:ICR) used FY2026 to move from pilot projects into contracted deployment, led by an estimated $8.8 million five-year agreement with mecwacare. Revenue and customer receipts more than doubled, although the company remains loss-making and reliant on disciplined rollout execution and further funding.
Victor Sage
13 Oct 2026

Healthcare Wrap - Week 31 (27 July -> 31 July) 2026

Xenitra led the healthcare board after a three-year Chinese pharmaceutical deal, while Artrya and InteliCare delivered the week’s biggest contrasting moves. Across the sector, companies raised cash, won regulatory support and pushed deeper into US hospitals and clinics.
Logan Eniac
1 Aug 2026

Technology Wrap - Week 31 (27 July -> 31 July) 2026

Appen led the technology market with a 45.73% weekly rise, while Synertec and InteliCare also gained more than 27%.
AI services, defence systems, critical infrastructure and recurring software revenue drove the week’s strongest company updates.
Logan Eniac
1 Aug 2026

InteliCare Hits Positive Cash Flow Milestone Amid Rapid Aged Care Rollouts

InteliCare generated positive cash flow for the first time since listing in the June 2026 quarter, driven by accelerated deployments across aged care and retirement living sectors.
Ada Torres
29 July 2026

InteliCare Boosts Hardi Contract with 84-Bed Expansion and Nurse Call Rollout

InteliCare has expanded its agreement with Hardi Aged Care by adding 84 beds at Blacktown and initiating a phased Nurse Call system deployment across six facilities, lifting contract value by 13%.
Sophie Babbage
28 July 2026

Healthcare Wrap - Week 25 (15 June -> 19 June) 2026

Healthcare stocks split into two camps this week: names with fresh data or contracts found buyers, while capital raisings and trial shock sent others sharply lower. The biggest move came from Cynata’s return to trade, but steady progress in Alzheimer’s, oncology, diagnostics and aged care software also kept the sector busy.
Logan Eniac
20 June 2026

InteliCare Advances Commercial Rollout with $8.8M mecwacare Contract

InteliCare (ASX:ICR) is hitting a commercial inflection point, backed by a landmark $8.8 million contract with mecwacare and a growing pipeline across aged care sectors. Its AI-powered platform promises measurable improvements in care outcomes and operational efficiency.
Ada Torres
16 June 2026

Technology Wrap - Week 19 (4 May -> 8 May) 2026

Small-cap tech buyers chased AI, defence and digital infrastructure this week, while a few names gave back gains after reopening jumps. The biggest moves came from contract wins, fresh capital and clear signs that products are getting closer to real sales.
Logan Eniac
9 May 2026

InteliCare Raises $2.05M Placement to Accelerate Commercial Scale-Up

InteliCare has secured A$2.05 million through a placement to back its commercial expansion following major aged care contracts and initial retirement village deployments.
Sophie Babbage
7 May 2026

Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026

Biotech price swings were led by Dimerix’s slide, while TrivarX and LTR Pharma surged on clinical and commercial progress. Capital raisings, FDA milestones and first sales kept healthcare investors busy, but several early jumps faded as traders locked in gains.
Logan Eniac
2 May 2026